The continuous rise in medicine prices could pose serious risks to public health as it is becoming increasingly difficult for chronic patients to continue their treatment, potentially triggering a major health crisis.
As per local media report, prices of several medicines across the country have increased by 10 to over 100 percent. This sharp rise has made treatment unaffordable for ordinary citizens, particularly those suffering from chronic illnesses.
Prices of commonly used medicines, including antibiotics, painkillers, and drugs for diabetes, blood pressure, stomach issues, ulcers, piles, allergies, skin conditions, and cough, have all gone up substantially.
The price of Tronolane cream, used for piles treatment, has risen from Rs85 to Rs290. The cost of Depricap , a medicine for mental health conditions, has increased from Rs900 to Rs999, while Sangobion is now being sold at Rs330, up from Rs300.
Similarly, the antibiotic Novidate has increased from Rs430 to Rs445, while Cefix DB has gone up from Rs410 to Rs530. The price of Entamizole syrup for stomach issues has risen from Rs135 to Rs150, and Methachlor eye drops now cost Rs102, up from Rs87.
The price of BV Dox has also increased from Rs500 to Rs600. In addition, medicines such as Strosoda, Dytor, Surbex Z, Lysomate Lotion, Mets, Deprecap, Kerycef, Cefix, Azytma, Acifile, and have all seen notable price hikes.
Experts warn that if the trend continues, it could severely impact healthcare access, especially for vulnerable populations dependent on long-term medication.
